Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-033906
Filing Date
2023-07-21
Accepted
2023-07-21 21:11:46
Documents
1
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12281
  Complete submission text file 0000950170-23-033906.txt   13940
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN CORPORATION PLC 77 SIR JOHN ROGERSON'S QUAY, BLOCK C DUBLIN 2 L2 D02 VK60
Business Address
O'Connor Oliver (Reporting) CIK: 0001973902 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 231103608